首页 | 本学科首页   官方微博 | 高级检索  
检索        

塞来昔布诱导急性早幼粒细胞白血病细胞株MR2凋亡及机制的研究
引用本文:胥昀,赵妍敏,黄河,曾芬芳,周倩.塞来昔布诱导急性早幼粒细胞白血病细胞株MR2凋亡及机制的研究[J].浙江大学学报(医学版),2007,36(4):319-324.
作者姓名:胥昀  赵妍敏  黄河  曾芬芳  周倩
作者单位:浙江大学医学院,附属第一医院骨髓移植中心、血液研究所,浙江,杭州,310003
基金项目:国家重点基础研究发展计划(973计划);国家自然科学基金
摘    要:目的:探讨塞来昔布诱导急性早幼粒细胞白血病细胞株MR2细胞凋亡作用及其可能机制。方法:应用MTT法分析塞来昔布对细胞增殖的影响;琼脂糖凝胶电泳进行DNA片段化分析;流式细胞仪检测细胞凋亡情况;PCR检测融合基因PML/RARα和凋亡相关基因Survivin表达;免疫印迹检测caspase-3、9和PARP蛋白表达。结果:MTT示塞来昔布对MR2细胞具有明显的增殖抑制作用,并具有时间和剂量依赖性。琼脂糖凝胶电泳见DNA片段化,形成典型梯状条带。流式细胞仪检测发现塞来昔布处理24 h后,随着作用浓度增加,MR2细胞早期凋亡率从5.06%增至36.1%,细胞内Survivin表达降低而PML/RARα无明显变化。同时伴有caspase-3、9和PARP蛋白的激活。结论:塞来昔布能够通过诱导凋亡抑制MR2细胞增殖,其机制可能与抑制Survivin表达有关,但与融合基因PML/RARα无明显关系。

关 键 词:白血病  早幼粒细胞  急性/病理生理学  白血病  早幼粒细胞  急性/药物疗法  塞来昔布/药理学  MR2细胞  凋亡  机制
文章编号:1008-9292(2007)04-0319-06
修稿时间:2007-03-02

Celecoxib-induced apoptosis in acute promyelocytic leukemia cell line MR2 and its mechanism
XU Yun,ZHAO Yan-min, HUANG He,et al.Celecoxib-induced apoptosis in acute promyelocytic leukemia cell line MR2 and its mechanism[J].Journal of Zhejiang University(Medical Sciences),2007,36(4):319-324.
Authors:XU Yun  ZHAO Yan-min  HUANG He  
Institution:Bone Marrow Transplantation Center,Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003 ,China
Abstract:OBJECTIVE: To investigate celecoxib-induced apoptosis of acute promyelocytic leukemia cell line MR2 and related mechanism. METHODS: MR2 cells were treated with celecoxib at different concentrations (0, 20, 40, 80, 120 and 160 micromol/L). The proliferation of MR2 cells was observed by MTT assay and apoptosis was detected by DNA fragmentation analysis and flow cytometry with Annexin V-FITC?PI staining. The expression of survivin and PML/RARalpha mRNA was examined by RT-PCR and nested-PCR, and the protein expression of caspase-3, 9 and PARP was analyzed by Western-blot. RESULTS: After treatment with celecoxib the viability of MR2 cells decreased markedly in a dose- and time-dependent manner, and a DNA ladder pattern of internucleosomal fragmentation was observed. The translocation of phosphatidylserine at the outer surface of the cell plasma membrane was induced by celecoxib and its level increased following the augmentation of the drug concentration. The expression of survivin mRNA decreased dramatically while no significant change with PML/RARalpha. Treatment with celecoxib for 24 h resulted in the activation of caspase-3 and 9, cleavage of PARP. CONCLUSION: Celecoxib could inhibit MR2 cell proliferation by inducing apoptosis, which might be mediated by the caspase-3 and 9 activation and PARP cleavage. Moreover, the down-regulation of survivin may play a certain role in apoptosis of MR2 cells induced by celecoxib.
Keywords:Leukemia  promyelocytic  acute/physiopathol  Leukemia  promyelocytic  acute/Drug ther  Celecoxib/pharmacol  MR2 cell  Apoptosis  Mechanisms
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号